1 |
Lee YM, Chen HW, Maurya PK, et al (2012). MicroRNA regulation via DNA methylation during the morula to blastocyst transition in mice. Mol Hum Reprod, 18, 184-93.
DOI
ScienceOn
|
2 |
Lewis BP, Burge CB , Bartel DP (2005). Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell, 14, 15-20.
|
3 |
Lin PC, Chiu YL, Banerjee S, et al (2013). Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. Cancer Res, 73, 1232-44.
DOI
|
4 |
Luan S, Sun L, Huang F (2010). MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251. Arch Med Res, 41, 67-74.
DOI
ScienceOn
|
5 |
Lu J, Getz G, Miska EA, et al (2005). MicroRNA expression profiles classify human cancers. Nature, 435, 834-8.
DOI
ScienceOn
|
6 |
Lu Y, Thomson JM, Wong HY, et al (2007). Transgenic overexpression of the microRNA miR-17-92 cluster promotes proliferation and inhibits differentiation of lung epithelial progenitor cells. Dev Biol, 310, 442-53.
DOI
ScienceOn
|
7 |
Liang YJ, Wang QY, Zhou CX, et al (2013). MiR-124 Targets Slug to Regulate Epithelial-to-Mesenchymal Transition and Metastasis of Breast Cancer. Carcinogenesis, 34, 713-22.
DOI
ScienceOn
|
8 |
Li JY, Zhang Y, Zhang WH, et al (2012). Differential distribution of miR-20a and miR-20b may underly metastatic heterogeneity of breast cancers. Asian Pac J Cancer Prev, 13, 1901-6.
DOI
ScienceOn
|
9 |
Lodish HF, Zhou B, Liu G, et al (2008). Micromanagement of the immune system by microRNAs. Nat Rev Immuno, l8, 120-30.
|
10 |
Madhavan D, Zucknick M, Wallwiener M, et al (2012). Circulating miRNAs as surrogate markers for circulating tumor cells and prognostic markers in metastatic breast cancer. Clin Cancer Res, 18, 5972-82.
DOI
ScienceOn
|
11 |
Yuan Y, Zeng ZY, Liu XH, et al (2011). MicroRNA-203 inhibits cell proliferation by repressing Np63 expression in human esophageal squamous cell carcinoma. BMC Cancer, 11, 57.
DOI
ScienceOn
|
12 |
Baffa R, Fassan M, Volinia S, et al (2009). MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol, 219, 214-21.
DOI
ScienceOn
|
13 |
Boldrup L, Coates PJ, Wahlgren M, et al (2012). Subsite-based alterations in miR-21, miR-125b, and miR-203 in squamous cell carcinoma of the oral cavity and correlation to important target proteins. J Carcinog, 11, 18.
DOI
|
14 |
Botezatu A, Goia-Rusanu CD, Iancu IV, et al (2011). Quantitative analysis of the relationship between microRNA 124a,-34b and-203 gene methylation and cervical oncogenesis. Mol Med Report, 4, 121-8.
|
15 |
Cheung TH, Man KN, Yu MY, et al (2012). Dysregulated microRNAs in the pathogenesis and progression of cervical neoplasm. Cell Cycle, 11, 2876-84.
DOI
ScienceOn
|
16 |
Craig VJ, Cogliatti SB, Rehrauer H, et al (2011). Epigenetic silencing of microRNA-203 dysregulates ABL1 expression and drives Helicobacter-associated gastric lymphomagenesis. Cancer Res, 71, 3616-24.
DOI
|
17 |
Huang G, Nishimoto K, Zhou Z, et al (2012). miR-20a encoded by the miR-17-92 cluster increases the metastatic potential of osteosarcoma cells by regulating Fas expression. Cancer Res, 72, 908-16.
DOI
|
18 |
Flynt AS , Lai EC (2008). Biological principles of microRNAmediated regulation: shared themes amid diversity. Nat Rev Genet, 9, 831-42.
DOI
ScienceOn
|
19 |
Gu J, Wang Y, Wu X (2013). MicroRNA in the Pathogenesis and Prognosis of Esophageal Cancer. Curr Pharm Des, 19, 1292-300.
DOI
|
20 |
Hayashita Y, Osada H, Tatematsu Y, et al (2005). A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation. Cancer Res, 65, 9628-32.
DOI
ScienceOn
|
21 |
Hu X, Schwarz JK, Lewis JS Jr, et al (2010). A microRNA expression signature for cervical cancer prognosis. Cancer Res, 70, 1441-8.
DOI
|
22 |
Jiang J, Lee EJ, Gusev Y, et al (2005). Real-time expression profiling of microRNA precursors in human cancer cell lines. Nucl Acids Res, 33, 5394-403.
DOI
ScienceOn
|
23 |
Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90.
DOI
|
24 |
Kang HW, Wang F, Wei Q, et al (2012). miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells. FEBS Lett, 586, 897-904.
DOI
ScienceOn
|
25 |
Lagos-Quintana M, Rauhut R, Lendeckel W, et al (2001). Identification of novel genes coding for small expressed RNAs. Science, 294, 853-8.
DOI
ScienceOn
|
26 |
Lee JW, Choi CH, Choi JJ, et al (2008). Altered microRNA expression in cervical carcinomas. Clin Cancer Res, 14, 2535-42.
DOI
ScienceOn
|
27 |
Lee RC, Ambros V (2001). An extensive class of small RNAs in Caenorhabditis elegans. Science, 294, 862-4.
DOI
ScienceOn
|
28 |
Ota A, Tagawa H, Karnan S, et al (2004). Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Res, 64, 3087-95.
DOI
ScienceOn
|
29 |
Ma Y, Zhang P, Wang F, et al (2012). Elevated oncofoetal miR-17-5p expression regulates colorectal cancer progression by repressing its target gene P130. Nat Commun, 3, 1291.
DOI
ScienceOn
|
30 |
Naoki I, Kenoki O, Kazuhiro M, et al (2010). MicroRNA-203 expression as a new prognostic marker of pancreatic adenocarcinoma. Ann Surg Oncol, 17, 3120-28.
DOI
|
31 |
Stadler BM, Ruohola-Baker H (2008). Small RNAs: keeping stem cells in line. Cell, 132, 563-6.
DOI
ScienceOn
|
32 |
Takeshita N, Mori M, Kano M, et al (2012). miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1. Int J Oncol, 41, 1653-61.
|
33 |
Ventura A, Young AG, Winslow MM, et al (2008). Targeted deletion reveals essential and overlapping functions of the miR-17 through 92 family of miRNA clusters. Cell, 132, 875-86.
DOI
ScienceOn
|
34 |
Venturini L, Battmer K, Castoldi M, et al (2007). Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells. Blood, 109, 4399-405.
DOI
ScienceOn
|
35 |
Viticchie G, Lena AM, Latina A, et al (2011). MiR-203 controls proliferation, migration and invasive potential of prostate cancer cell lines. Cell Cycle, 10, 1121-31.
DOI
|
36 |
Wang W, Corrigan-Cummins M, Hudson J, et al (2012). MicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor response. Haematologica, 97, 586-94.
DOI
|
37 |
Xiao C, Srinivasan L, Calado DP, et al (2008). Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes. Nat Immunol, 9, 405-14.
DOI
ScienceOn
|